A prospective single‐centre evaluation of the intra‐individual variability of faecal calprotectin in quiescent <scp>C</scp>rohn's disease

Abstract

Day to day variability of faecal calprotectin is low in our cohort of quiescent Crohn's disease patients and the reliability of defining a 'case' is moderately good. These data provide reassurance to clinicians using a single calprotectin sample to inform therapeutic strategies in this cohort.